We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$497M
AUM Growth
+$311M
Cap. Flow
+$292M
Cap. Flow %
58.74%
Top 10 Hldgs %
40.05%
Holding
208
New
119
Increased
8
Reduced
26
Closed
40
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCLS
126
Q/C Technologies Inc
QCLS
$22.3M
$403K 0.08%
+45
New +$552K
LQDA icon
127
Liquidia Corp
LQDA
$7.72B
$393K 0.08%
+133,069
New +$489K
SHIPZ
128
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$391K 0.08%
+727,000
New +$35K
RNLX
129
DELISTED
Renalytix plc American Depositary Shares
RNLX
$367K 0.07%
22,960
-13,040
-36% -$161K
PEB icon
130
Pebblebrook Hotel Trust
PEB
$2.2B
$357K 0.07%
19,000
-11,000
-37% -$178K
BLCM
131
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$350K 0.07%
+99,103
New +$418K
LSTA icon
132
Lisata Therapeutics
LSTA
$10.6M
$345K 0.07%
+16,072
New +$381K
MIST icon
133
Milestone Pharmaceuticals
MIST
$133M
$336K 0.07%
+50,113
New +$336K
FRT icon
134
Federal Realty Investment Trust
FRT
$10.9B
$323K 0.06%
3,800
NCNA
135
NuCana
NCNA
$5.37M
$313K 0.06%
+14
New +$336K
UG icon
136
United-Guardian
UG
$33.7M
$303K 0.06%
+21,067
New +$308K
RCEL icon
137
Avita Medical
RCEL
$142M
$296K 0.06%
+15,954
New +$350K
ALNA
138
DELISTED
Allena Pharmaceuticals
ALNA
$278K 0.06%
+217,251
New +$303K
MTLS
139
Materialise
MTLS
$373M
$271K 0.05%
+5,000
New +$223K
AKBA icon
140
Akebia Therapeutics
AKBA
$341M
$267K 0.05%
+95,342
New +$278K
CTAC.U
141
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$267K 0.05%
+25,000
New +$254K
FLACU
142
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$260K 0.05%
+25,000
New +$261K
CLVR
143
CALL
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$253K 0.05%
+947
New +$307K
BMY icon
144
Bristol-Myers Squibb
BMY
$130B
$249K 0.05%
+360,700
New +$22.2M
CLPS icon
145
CLPS Inc
CLPS
$24.5M
$249K 0.05%
+81,814
New +$254K
KIN
146
DELISTED
Kindred Biosciences, Inc.
KIN
$247K 0.05%
+57,277
New +$233K
MTVA
147
MetaVia Inc
MTVA
$7.39M
$239K 0.05%
+17
New +$256K
PHIOW
148
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$232K 0.05%
+86,299
New +$13.1K
INBS icon
149
Intelligent Bio Solutions
INBS
$3.8M
$230K 0.05%
+13
New +$285K
ETTX
150
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$229K 0.05%
+92,626
New +$182K

Similar funds

Anson Funds Management's Q4 2020 Portfolio in Review

As of Q4 2020, Anson Funds Management held 208 positions worth $497M, up 166% from $187M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Anson Funds Management deployed $292M of net new capital in Q4 2020, opening 119 new positions and adding to 8 existing holdings. Its largest new stake was Lucid Motors: 230,640 shares worth $23.1M.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 2.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Whole Earth Brands, Inc. Class A Common Stock, an estimated $6.23M trimmed.

  • Anson Funds Management's largest Q4 2020 buy was Lucid Motors: 230,640 shares worth $23.1M.
  • Anson Funds Management added most to Equity Distribution Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q4 2020, an estimated $9.02M increase.
  • Anson Funds Management's biggest Q4 2020 reduction was Whole Earth Brands, Inc. Class A Common Stock, cutting an estimated $6.23M.
  • Anson Funds Management fully exited Desktop Metal, Inc. in Q4 2020, selling an estimated $8.9M.
  • Anson Funds Management's ten largest holdings make up 40% of its $497M portfolio in Q4 2020.
  • Anson Funds Management opened 119 new positions and closed 40 in Q4 2020.
  • Anson Funds Management's portfolio value rose 166% quarter-over-quarter to $497M.

Based on Anson Funds Management's 13F filing for Q4 2020, filed 16 Feb 2021.